Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,304.87 +58.19 (+1.11%) Dow
39,883.91 +325.80 (+0.82%) Nasdaq
16,740.87 +229.69 (+1.39%) Bitcoin USD
66,442.30 +4,836.84 (+7.85%) CMC Crypto 200
1,389.55 +121.60 (+9.59%)
DGX May 2024 150.000 put
- Fortune
Employees are cheating on workplace drug tests at record rates—and legalized cannabis could be to blame
A rise in the use of recreational marijuana use in states that have legalized cannabis appears to be behind a spike in falsified workplace drug tests.
- Benzinga
Employers Struggle with Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High
Cheating on drug tests among American workers has surged to its highest level in over 30 years, according to a lab report from Quest Diagnostics Inc (NASDAQ:DGX). The lab reported that approximately 31,000 out of 5.5 million drug tests showed signs of tampering in 2023. Dr. Suhash Harwani, senior director of science for workforce health solutions at Quest, highlighted the lengths some individuals go to subvert the drug-testing process. The steady rate of positive drug tests, combined with an inc
- PR Newswire
Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests
The percentage of employees in the general U.S. workforce whose drug test showed signs of tampering increased by more than six-fold in 2023 versus the prior year, the highest rate ever in more than 30 years of annual reporting. This finding is part of a new analysis of nearly 9.8 million workforce drug tests released today by Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services. To view the full report, visit www.QuestDiagnostics.com/DTI.
